Novartis Ag (NVS) Enterprise Value (2009 - 2026)

Novartis Ag (NVS) has 16 years of Enterprise Value data on file, last reported at $315.0 million in Q1 2026.

• Quarterly Enterprise Value rose 162.5% year-over-year to $315.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$105.0 million (up 91.17% YoY) and the FY2025 annual result came in at -$2.3 billion, down 1099.48% from the prior year.
• Enterprise Value grew to $315.0 million in Q1 2026 per NVS's latest filing, from -$2.3 billion in the prior quarter.
• The five-year high for Enterprise Value was $13.2 billion in Q2 2022, with the low at -$18.8 billion in Q4 2022.
• Average Enterprise Value over 5 years is -$2.7 billion, with a median of -$193.0 million recorded in 2024.
• Year-over-year, Enterprise Value surged 45503.45% in 2022 and tumbled 5613.33% in 2023.
• Novartis Ag's Enterprise Value stood at -$18.8 billion in 2022, then jumped by 32.79% to -$12.7 billion in 2023, then jumped by 98.48% to -$193.0 million in 2024, then sank by 1099.48% to -$2.3 billion in 2025, then jumped by 113.61% to $315.0 million in 2026.
• Business Quant data shows NVS's Enterprise Value at $315.0 million in Q1 2026, -$2.3 billion in Q4 2025, and $225.0 million in Q3 2025.